Form 4: Natera CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

Steven Leonard Chapman, Natera's CEO and President, sold 5,079 shares of common stock on September 2, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Steven Leonard Chapman, CEO and President of Natera, Inc. (NTRA), reported the sale of common stock.
• The transactions occurred on September 2, 2025.
• A total of 5,079 shares were sold across three separate transactions.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 11, 2023, and amended on December 2, 2024.
• The weighted average sale prices were $165.4368, $166.286, and $167.6872 per share.
• Following these transactions, Mr. Chapman directly beneficially owns 158,514 shares of Natera common stock.

Sentiment

Score: 5

Explanation: The sale of shares by the CEO is generally a neutral event when conducted under a pre-arranged 10b5-1 plan, as it indicates planned diversification or liquidity rather than a reaction to new, undisclosed negative information. The volume is not excessively large relative to total holdings.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent approach to insider stock transactions rather than an immediate reaction to new information.

Negatives

• The CEO's direct beneficial ownership of Natera common stock decreased by 5,079 shares, which could be perceived as a reduction in direct alignment with shareholder interests, although mitigated by the 10b5-1 plan.

Risks

• While the sale was pre-planned, significant insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence, potentially leading to negative sentiment.

Stakeholder Impact

• Shareholders: The sale, while pre-planned, slightly reduces the CEO's direct equity stake, which some investors might view with slight caution, though the 10b5-1 plan mitigates concerns about opportunistic selling.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled insider stock sale under a 10b5-1 plan. Such transactions are typically not indicative of new material information about the company's performance or prospects and therefore do not warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate Natera based on its fundamental business performance and broader market conditions.

Keywords

Natera, NTRA, Steven Leonard Chapman, CEO, President, Form 4, insider trading, stock sale, 10b5-1 plan, common stock, beneficial ownership